| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Supply impact start date | Availability | Reason | Last updated |
| betiatide | Injection, powder for | 1 mg | Current | 30/04/2024 | Unavailable | Manufacturing | 10/05/2024 |
| eplerenone | Tablet, film coated | 25 mg | Resolved | 2/04/2024 | Available | Unexpected increase in consumer demand | 10/05/2024 |
| paracetamol~codeine phosphate hemihydrate~doxylamine succinate | Tablet, uncoated | 450 mg~30 mg~5 mg | Resolved | 2/05/2024 | Available | Manufacturing | 10/05/2024 |
| morphine sulfate pentahydrate | Injection, solution | 15 mg | Discontinued | | Reduction in supply until supply is exhausted | Unexpected increase in demand due to other sponsors unable to supply | 10/05/2024 |
| lisinopril dihydrate | Tablet, uncoated | 10.89 mg | Anticipated | 13/09/2024 | Available | Unexpected increase in demand due to other sponsors unable to supply | 10/05/2024 |
| fosamprenavir calcium | Tablet, film coated | 853.2 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 10/05/2024 |
| gabapentin | Capsule, hard | 400 mg | Resolved | 21/02/2024 | Available | Manufacturing | 10/05/2024 |
| irbesartan | Tablet, film coated | 75 mg | Discontinued | | Reduction in supply until supply is exhausted | Unexpected increase in consumer demand | 10/05/2024 |
| irbesartan | Tablet, film coated | 75 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 10/05/2024 |
| levonorgestrel~levonorgestrel~levonorgestrel~ethinylestradiol~ethinylestradiol | Tablet, sugar coated | .05 mg~.075 mg~.125 mg~.04 mg~.03 mg | Discontinued | | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 10/05/2024 |
| bortezomib | Injection, powder for | 3.5 mg | Discontinued | | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 10/05/2024 |
| indometacin | Suppository, moulded | 100 mg | Resolved | 14/03/2024 | Available | Manufacturing | 10/05/2024 |
| cilastatin~imipenem | Injection, powder for | 500 mg~500 mg | Discontinued | | Reduction in supply until supply is exhausted | Unexpected increase in consumer demand | 10/05/2024 |
| paclitaxel | Injection, concentrated | 6 mg/mL | Resolved | 29/02/2024 | Available | Manufacturing | 9/05/2024 |
| fulvestrant | Injection, solution | 50 mg/mL | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 9/05/2024 |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Current | 3/04/2024 | Limited Availability | Unexpected increase in consumer demand | 9/05/2024 |
| tobramycin | Injection, solution | 80 mg | Current | 29/06/2023 | Unavailable | Manufacturing | 9/05/2024 |
| methotrexate | Injection, solution | 1000 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 9/05/2024 |
| potassium chloride | Injection, concentrated | 750 mg | Resolved | 5/05/2023 | Available | Manufacturing | 9/05/2024 |
| sodium chloride | Injection, intravenous infusion | 450 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 9/05/2024 |
| amantadine hydrochloride | Capsule, soft | 100 mg | Resolved | 8/02/2024 | Available | Commercial Changes / Commercial viability | 9/05/2024 |
| tetracosactide | Injection, modified release | 1 mg/mL | Current | 1/02/2019 | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 9/05/2024 |
| chlorhexidine gluconate | Solution, irrigation | 30 mg | Anticipated | 1/06/2024 | Available | Transport / Logistic issues / Storage capacity issues | 9/05/2024 |
| thallous(201Tl) chloride | Injection, solution | 74 MBq/mL | Current | 1/08/2021 | Unavailable | Manufacturing | 9/05/2024 |
| sodium chloride | Solution, irrigation | 270 mg | Resolved | 17/02/2023 | Available | Manufacturing | 9/05/2024 |
| atropine sulfate monohydrate | Injection, solution | 1.2 mg/mL | Anticipated | 31/05/2024 | Available | Transport / Logistic issues / Storage capacity issues | 9/05/2024 |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.7 mg | Resolved | 11/03/2024 | Available | Transport / Logistic issues / Storage capacity issues | 9/05/2024 |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.8 mg | Resolved | 25/09/2023 | Available | Unexpected increase in consumer demand | 9/05/2024 |
| cytarabine | Injection, solution | 1 g | Discontinued | | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 9/05/2024 |
| povidoneiodine | Application | 50 mg/mL | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 9/05/2024 |
| gentamicin | Injection, solution | 80 mg | Anticipated | 1/11/2024 | Available | Manufacturing | 9/05/2024 |
| hydrogen peroxide | Solution | 30 mg/mL | Current | 30/08/2023 | Unavailable | Transport / Logistic issues / Storage capacity issues | 8/05/2024 |
| indapamide hemihydrate~perindopril erbumine | Tablet, uncoated | 1.25 mg~4 mg | Discontinued | | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 8/05/2024 |
| erlotinib hydrochloride | Tablet, film coated | 27.32 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 8/05/2024 |
| erlotinib hydrochloride | Tablet, film coated | 109.29 mg | Discontinued | | Unavailable | Manufacturing | 8/05/2024 |
| erlotinib hydrochloride | Tablet, film coated | 163.93 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 8/05/2024 |
| salbutamol sulfate | Inhalation, conventional | 3 mg | Current | 30/12/2022 | Unavailable | Manufacturing | 8/05/2024 |
| calcium folinate | Injection | 324.1 mg | Resolved | 27/06/2023 | Available | Manufacturing | 8/05/2024 |
| clarithromycin | Tablet, film coated | 250 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 8/05/2024 |
| acetylcholine chloride | Solution, powder for irrigation | 10 mg/mL | Current | 15/09/2023 | Unavailable | Transport / Logistic issues / Storage capacity issues | 8/05/2024 |
| colestyramine | Powder, oral | 850 mg/g | Current | 30/03/2023 | Limited Availability | Manufacturing | 8/05/2024 |
| adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride | Injection, solution | 9.1 microgram/mL~5 mg/mL | Current | 22/12/2021 | Unavailable | Unexpected increase in consumer demand | 8/05/2024 |
| adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride | Injection, solution | 9.1 microgram/mL~20 mg/mL | Current | 19/10/2023 | Unavailable | Transport / Logistic issues / Storage capacity issues | 8/05/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.7 mg | Current | 29/04/2024 | Limited Availability | Manufacturing | 8/05/2024 |
| duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Anticipated | 15/08/2024 | Available | Manufacturing | 8/05/2024 |
| metformin hydrochloride | Tablet, modified release | 500 mg | Current | 16/04/2020 | Unavailable | Manufacturing | 8/05/2024 |
| hydroxocobalamin chloride | Injection, solution | 1.027 mg | Current | 3/05/2024 | Limited Availability | Transport / Logistic issues / Storage capacity issues | 8/05/2024 |
| perindopril erbumine | Tablet, uncoated | 2 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 8/05/2024 |
| perindopril erbumine | Tablet, uncoated | 4 mg | Discontinued | | Unavailable | Manufacturing | 8/05/2024 |
| perindopril erbumine | Tablet, uncoated | 8 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 8/05/2024 |
| glimepiride | Tablet, uncoated | 1 mg | Resolved | 13/10/2023 | Available | Unexpected increase in demand due to other sponsors unable to supply | 8/05/2024 |
| glimepiride | Tablet, uncoated | 2 mg | Resolved | 3/11/2023 | Available | Commercial Changes / Commercial viability | 8/05/2024 |
| glimepiride | Tablet, uncoated | 3 mg | Current | 14/04/2023 | Unavailable | Commercial Changes / Commercial viability | 8/05/2024 |
| medroxyprogesterone acetate | Injection, suspension | 150 mg/mL | Discontinued | | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 8/05/2024 |
| ciprofloxacin | Injection, solution | 200 mg | Discontinued | | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 8/05/2024 |
| ciprofloxacin | Injection, solution | 400 mg | Discontinued | | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 8/05/2024 |
| carvedilol | Tablet, film coated | 12.5 mg | Current | 2/11/2023 | Unavailable | Commercial Changes / Commercial viability | 8/05/2024 |
| varenicline tartrate~varenicline tartrate | Tablet, film coated | 1.71 mg~.85 mg | Current | 4/06/2021 | Unavailable | Commercial Changes / Commercial viability | 8/05/2024 |
| varenicline tartrate | Tablet, film coated | 1.71 mg | Current | 4/06/2021 | Unavailable | Commercial Changes / Commercial viability | 8/05/2024 |
| warfarin sodium | Tablet, uncoated | 1 mg | Resolved | 19/01/2024 | Available | Manufacturing | 7/05/2024 |
| warfarin sodium | Tablet, uncoated | 5 mg | Current | 23/04/2024 | Limited Availability | Transport / Logistic issues / Storage capacity issues | 7/05/2024 |
| amisulpride | Tablet, uncoated | 100 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 7/05/2024 |
| efavirenz | Tablet, film coated | 200 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 7/05/2024 |
| salbutamol sulfate | Inhalation | 1.2 mg/mL | Resolved | 15/11/2023 | Available | Transport / Logistic issues / Storage capacity issues | 7/05/2024 |
| trandolapril | Capsule | .5 mg | Current | 13/02/2024 | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 7/05/2024 |
| perindopril erbumine | Tablet, uncoated | 4 mg | Discontinued | | Unavailable | Manufacturing | 7/05/2024 |
| perindopril erbumine | Tablet, uncoated | 8 mg | Discontinued | | Unavailable | Transport / Logistic issues / Storage capacity issues | 7/05/2024 |
| metformin hydrochloride | Tablet, film coated | 850 mg | Resolved | 13/10/2023 | Available | Manufacturing | 7/05/2024 |
| water for injections~Mumps virus~Rubella virus~Measles virus~live varicella vaccine | Injection, diluent for~Injection, powder for | .75 mL~4.3 TCID50~3 TCID50~3 TCID50~3.99 PFU | Current | 30/06/2023 | Unavailable | Manufacturing | 7/05/2024 |
| risperidone | Tablet, film coated | 3 mg | Resolved | 13/10/2023 | Available | Manufacturing | 7/05/2024 |
| meloxicam | Tablet, uncoated | 7.5 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 7/05/2024 |
| meloxicam | Tablet, uncoated | 15 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 7/05/2024 |
| povidoneiodine | Application | 100 mg/mL | Current | 27/05/2022 | Unavailable | Manufacturing | 7/05/2024 |
| hydrochlorothiazide~enalapril maleate | Tablet, uncoated | 6 mg~20 mg | Current | 23/03/2021 | Unavailable | Manufacturing | 7/05/2024 |
| daunorubicin | Injection, solution | 20 mg | Current | 28/03/2024 | Limited Availability | Transport / Logistic issues / Storage capacity issues | 7/05/2024 |
| bupivacaine hydrochloride monohydrate | Injection, solution | 105.4 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 7/05/2024 |
| meloxicam | Tablet, uncoated | 15 mg | Resolved | 3/01/2024 | Available | Manufacturing | 7/05/2024 |
| lisinopril dihydrate | Tablet, uncoated | 21.78 mg | Discontinued | | Unavailable | Manufacturing | 7/05/2024 |
| phenoxybenzamine hydrochloride | Capsule, hard | 10 mg | Current | 1/10/2008 | Unavailable | Manufacturing | 7/05/2024 |
| ramipril | Tablet, uncoated | 1.25 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 7/05/2024 |
| ramipril | Tablet, uncoated | 2.5 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 7/05/2024 |
| live varicella vaccine | Injection, powder for | 19400 PFU | Discontinued | | Unavailable | Manufacturing | 7/05/2024 |
| sodium pertechnetate(99mTc) | Injection, solution | 18.5 GBq | Current | 30/11/2020 | Unavailable | Manufacturing | 6/05/2024 |
| diltiazem hydrochloride | Capsule, modified release | 180 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 6/05/2024 |
| diltiazem hydrochloride | Capsule, modified release | 240 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 6/05/2024 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 6/05/2024 |
| paracetamol~codeine phosphate hemihydrate | Oral Liquid | 24 mg/mL~1 mg/mL | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 6/05/2024 |
| oxaliplatin | Injection, intravenous infusion | 100 mg | Current | 18/03/2024 | Limited Availability | Product recall | 6/05/2024 |
| morphine sulfate pentahydrate | Tablet, modified release | 10 mg | Current | 10/05/2022 | Unavailable | Manufacturing | 6/05/2024 |
| morphine sulfate pentahydrate | Tablet, modified release | 30 mg | Current | 18/11/2022 | Unavailable | Manufacturing | 6/05/2024 |
| morphine sulfate pentahydrate | Tablet, modified release | 60 mg | Current | 14/02/2023 | Unavailable | Manufacturing | 6/05/2024 |
| morphine sulfate pentahydrate | Tablet, modified release | 100 mg | Current | 19/04/2023 | Limited Availability | Unexpected increase in consumer demand | 6/05/2024 |
| sitagliptin phosphate monohydrate | Tablet, film coated | 128.5 mg | Discontinued | | Reduction in supply until supply is exhausted | Unexpected increase in consumer demand | 6/05/2024 |
| sitagliptin phosphate monohydrate | Tablet, film coated | 64.25 mg | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 6/05/2024 |
| sitagliptin phosphate monohydrate | Tablet, film coated | 32.13 mg | Discontinued | | Reduction in supply until supply is exhausted | Unexpected increase in consumer demand | 6/05/2024 |
| quinapril hydrochloride | Tablet, film coated | 21.664 mg | Discontinued | | Unavailable | Manufacturing | 6/05/2024 |
| sodium thiosulfate pentahydrate | Injection, solution | 2.5 g | Resolved | 7/08/2023 | Available | Manufacturing | 6/05/2024 |
| Interferon beta1a | Injection, solution | 88 microgram/mL | Discontinued | | Reduction in supply until supply is exhausted | Manufacturing | 6/05/2024TGAオーストラリア供給不足情報（4月22日～4月28日） |
